SPRY · ARS Pharmaceuticals, Inc. · Exempt Offerings
Market Cap
$558.89M
Shares
99.45M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1671858
CUSIP
82835W108
13F (30d)
134 filings
134 filers
Visit website
Investor relations